Nav: Home

Tumor of the touch cells: A first-of-its-kind study in India

February 17, 2020

The cause of a disease often affects its treatment plan. The need to fill this gap in our understanding of disease biology is further exaggerated in the case of 'rare' diseases.

So, what is a rare disease? Currently, there is no universal definition for a rare disease since it depends on the country's population and the availability of treatment. In the case of India, a disease is considered rare if less than one person among 5000 is affected by it. In such a scenario, the hope is that efforts are intensified to understand the biology of such rare conditions, strategize treatments and thus create some respite for those affected.

Motivated by one such rare disease and its cause, a team of researchers from the National Centre for Biological Sciences, Bangalore, a pathologist at the Tata Memorial Centre, Mumbai and scientists at ACTREC, Navi Mumbai, joined hands to study the basis of a skin cancer known as Merkel cell carcinoma (MCC). Their work, published in the journal of Microbial Pathogenesis is a first-of-its-kind study in the Indian population.

Merkel cell carcinoma is a type of cancer that triggers the uncontrolled growth of the Merkel cells of the skin. Also known as touch cells, these are found in close proximity to nerves and enable us to sense touch. Merkel cell tumors are typically caused by a combination of excessive UV-exposure, poor immunity and increased age. A change in the genetic make-up of the Merkel cells due to UV damage sometimes renders these cells to divide uncontrollably, leading to a reddish outgrowth on the skin - a sign of MCC.

More than a decade ago (2008), MCCs were also found to be associated with a virus known as the Merkel cell polyomavirus (MCV). This virus, though a part of our normal skin flora, may in some cases, undergo cancer-promoting changes or 'mutations'. When such a rare version of the MCV weaves itself into the genetic material of a Merkel cell, it could lead to MCC.

"A cancer caused by a virus is unique in its own right, as it offers an external target for therapy (the viral proteins). Since MCC comes in two forms, it was essential for us to first determine whether cases seen in India are virus positive or negative. This not only helps with determining prognosis, but also in designing treatment for this cancer," say Dr. Reety Arora, cancer cell biologist and Dr. Bharat Rekhi, pathologist, the two lead authors of the paper.

From a disease perspective, does it matter if the cancer is caused by UV or by the MCV? The answer is a resounding yes. Studies in the past have shown that MCCs caused by invasion of the polyomavirus are less aggressive and show lower progression, when compared to those that are caused due to UV damage. In India, only a handful of MCC cases have been reported, but none of them had been tested for the presence of the MCV. This void in MCC biology in the Indian cohort motivated Dr Reety Arora to begin her investigations.

With collaborative efforts of Dr. Bharat Rekhi from the Tata Memorial Centre, Dr. Reety Arora managed to include cancer tissue samples from 18 primary MCC patients, 11 of whom were men and the remaining 7, women. She first used a protein lock and key technique to identify the presence of the MCV Aka immunohistochemistry, which was utilized to test samples from 18 cases in Dr. Bharat Rekhi's laboratory at TMH. This technique involves the external addition of a protein (key) that can be visualized when it finds and binds to its specific partner protein (the lock), present in the tissue sample. In this case, a protein exclusively produced by the cancer-causing MCV was used as the lock that the externally added key would latch on to. Using this detection technique, Dr. Reety Arora and Dr. Bharat Rekhi discovered that 7 out of the 18 patients showed the presence of the MCV. This is the first time any group has been able to show the presence of MCV in Merkel cell tumors of Indian patients.

To complement the previous protein based detection technique, Dr. Reety Arora, along with Dr. Amit Dutt, used an additional commonly used genetic screening method (PCR) that would help her detect the viral genetic material. Interestingly, 8 out of the 12 samples tested showed the presence of the MCV genetic material. Twenty five percent (3/12) of the samples showed the presence of MCV through both the detection techniques, indicating that most MCC cases in India were likely caused by UV-linked damages.

"Considering MCCs are associated with high tumor mutation burden and therefore cases, especially with advanced disease, are being considered for immunotherapy, their exact diagnosis including testing for MCC polyomavirus as well as differentiation from their mimics is crucial", says Dr. Bharat Rekhi.

"Our group is invested in first understanding how Merkel cell polyomavirus causes Merkel cancer and then how we can intervene in both easier diagnosis and therapy," adds Dr. Reety Arora, who is keen on following up this study and hopeful that it will find fruition someday.
-end-


National Centre for Biological Sciences

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Meditations on Loneliness
Original broadcast date: April 24, 2020. We're a social species now living in isolation. But loneliness was a problem well before this era of social distancing. This hour, TED speakers explore how we can live and make peace with loneliness. Guests on the show include author and illustrator Jonny Sun, psychologist Susan Pinker, architect Grace Kim, and writer Suleika Jaouad.
Now Playing: Science for the People

#565 The Great Wide Indoors
We're all spending a bit more time indoors this summer than we probably figured. But did you ever stop to think about why the places we live and work as designed the way they are? And how they could be designed better? We're talking with Emily Anthes about her new book "The Great Indoors: The Surprising Science of how Buildings Shape our Behavior, Health and Happiness".
Now Playing: Radiolab

The Third. A TED Talk.
Jad gives a TED talk about his life as a journalist and how Radiolab has evolved over the years. Here's how TED described it:How do you end a story? Host of Radiolab Jad Abumrad tells how his search for an answer led him home to the mountains of Tennessee, where he met an unexpected teacher: Dolly Parton.Jad Nicholas Abumrad is a Lebanese-American radio host, composer and producer. He is the founder of the syndicated public radio program Radiolab, which is broadcast on over 600 radio stations nationwide and is downloaded more than 120 million times a year as a podcast. He also created More Perfect, a podcast that tells the stories behind the Supreme Court's most famous decisions. And most recently, Dolly Parton's America, a nine-episode podcast exploring the life and times of the iconic country music star. Abumrad has received three Peabody Awards and was named a MacArthur Fellow in 2011.